Navigation Links
New Research Shows Continuing Medical Education Saves Healthcare Costs
Date:5/29/2013

WEST HARTFORD, Conn., May 29, 2013 /PRNewswire-iReach/ -- A study has shown that continuing medical education (CME) can save significant costs to the healthcare system even when a modest number of doctors change their practice as a result of what they have learned. The research was presented on May 22 at the 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in New Orleans, LA. The study was conducted by CMEology, West Hartford, CT—a leader in CME and innovator in outcomes research—and presented by Dana Ravyn, PhD, MPH, Scientific Director and Senior Analyst at CMEology.

"With the changing nature of healthcare economics, there was a need to communicate the benefits of CME, and everyone understands costs," said Dr. Ravyn, "Studies have not typically evaluated the economic impact of CME because doing so requires extensive follow up that is both time consuming and cost prohibitive." Using computer models, the authors could inexpensively estimate the range of potential cost savings from CME activities. "Historically few, if any, rigorous economic models have been applied to understanding the impact of CME—by pioneering these efforts, this research is groundbreaking. Efforts like these must be recognized as the future of CME assessment," said Brian S. McGowan , PhD, Chief Learning Officer & Co-Founder of ArcheMedX, Inc. With the availability of these data, stakeholders are now able to make better decisions on how to allocate limited resources as well as evaluate CME programming economic outcomes.

The study evaluated the economic impact when cardiac and thoracic surgeons applied learning from a CME activity about the prevention of bleeding-related complications. The model base case predicted what would happen if 30% of learners prevented bleeding complications in 2% of their annual surgeries. The savings estimates ranged from $1.5 to $2.7 million, depending on the type of complication, and findings were similar to clinical trials evaluating cost savings from interventions.

One of the challenges faced by contemporary CME is the ability to demonstrate its value to stakeholders, healthcare payers, and society. According to Michael R. Lemon , MBA, FACEHP, CCMEP of Postgraduate Institute for Medicine "Few studies exist that demonstrate economic benefits or the cost effectiveness of CME. Therefore, the ability to demonstrate the impact of CME on healthcare costs is timely and needed, as economic data provide a universally understood outcome measure."

While significant for the findings related to surgical complications, the broader implication of this research is the creation of a model that can be applied to almost any therapy area and learning format. "New models for understanding the impact of CME are desperately needed and this work lays the foundation for a myriad of new questions being asked—and that is what science is all about," according to Dr. McGowan.

The study from CMEology comes at a crucial time for CME when segments of the healthcare environment are under pressure to cut budgets and enhance efficiency. CME has consistently demonstrated its importance to the professional development of healthcare providers, but the economic piece of the puzzle has been missing. "In a time of diminishing funding and increased scrutiny from all stakeholders, it is vital to prove the value of continuing education.  This study is documented validation of the importance of CME/CE and its impact on both healthcare costs and patient outcomes," said Nathan Scott , Education Director of Medical Education Resources.

For a copy of the research presentation go to http://bit.ly/valueofcme

Related links:

www.cmeology.org

www.archemedx.com

www.pimed.com

www.cmepartner.org

Media Contact: Rob Lowney CMEology, 860-236-1200, rlowney@cmeology.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CMEology
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports
2. Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)
3. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
4. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
5. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
6. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
7. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
8. Sony Biotechnology Inc.s New Technology for Science Provides Researchers Results in Color
9. Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
10. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
11. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/14/2017)... It should come as no surprise to anyone that ... of a crippling opioid epidemic. According to the Center ... deaths from opiate-based medications has quadrupled, Says, Dr. David ... 2001 to 2015". During this time, the prescription rate for ... a compelling link between prescription and eventual addiction. The problem ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... Cheerag D. Upadhyaya , ... Marion Bloch Neuroscience Institute (SLMBNI), part of Saint Luke’s Health System . ... , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins Stanley P. Fisher, M.D., ...
(Date:7/24/2017)... ... July 24, 2017 , ... BayMark Health Services ... Health Services Administration’s (SAMHSA) State Targeted Response to the Opioid Crisis program. ... will facilitate the development of a hub and spoke model for opioid treatment ...
(Date:7/24/2017)... ... July 24, 2017 , ... Peruvian Ayahuasca retreat, ... be awarded annually to and divided between two full-time university students enrolled in ... Amazonian plant medicine. To apply for the scholarship, students are asked to submit ...
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider ... partnered with WALLIX to expand its solution to help government contractors more ... a number of ways to address the authentication requirements within NIST SP800-171, but ...
(Date:7/24/2017)... ... 24, 2017 , ... A CDC study shows that, although people are taking more steps to ... 29), had at least one case of sunburn within the past year. It’s common and ... ignore the issue. However, only recently have people become conscientious of the risks that accompany ...
Breaking Medicine News(10 mins):